Pacira Biosciences Inc (PCRX)
smart-money factor below the score midpoint; trend factor above the score midpoint, relative-strength factor on the lower side vs the sector.
PCRX scores in the 48th percentile of Health Care by composite score (n=1,099 covered peers) this session.
As of 18 September 2026, Pacira Biosciences Inc (PCRX) scores 44 out of 100 on the Tapeline six-factor composite, which puts it in the NEUTRAL band — the descriptive name for scores of 40 to 54. The composite blends six named factors — trend, relative strength, fundamentals, smart money, macro and momentum — each normalised to 0-100. It records what those measurements read on 18 September 2026, and it is not investment advice.
Updated · scores usually change about once a day
Key statistics
Market fields as reported. An em-dash means we hold no value for this ticker — most of the universe has no daily price or volume read.
- Relative volume
- 0.23× 30-day average
- 52-week range
- 18.80 – 27.66
- Market cap
- $983.39M
- Earnings date
- —
- Volume
- 125,464
- Avg. volume (30d)
- 542,811
- Open
- 24.36
- Previous close
- 24.48
- Day's range (regular session)
- 24.20 – 24.72
The price is the last trade and includes extended-hours trading, so it can sit outside the regular-session range.
Shown without a peer ranking — we hold no percentile for these yet, so there is nothing here to locate them against.
- Beta
- —
- P/E (TTM)
- —
- EPS (TTM)
- —
Score breakdown · six named factors
The six factors are public and never change without a changelog entry. Read the full methodology on /how-it-works.
Premium data held for PCRX
- 1 SEC Form 4 insider transaction in the last 90 daysPremium
Counts of rows Tapeline holds for PCRX. A dash in the factor table above means that factor has no data for this ticker — it is not a locked value. Compare plans
What the score says about PCRX right now
Pacira Biosciences Inc (PCRX) currently scores 44/100 on the Tapeline six-factor composite, sitting in the NEUTRAL band. PCRX is +0.06% on the day and -3.13% over five sessions as of the most recent tick. NEUTRAL (40-54) means the six factors cancel each other. PCRX doesn't lean directionally on the composite right now. That's not bad — it's the band where you'd come back next week to see if any single factor breaks out of the equilibrium. PCRX's strongest factor is Trend at 76/100 — a strong read on the multi-week technical structure. Trend reads how far price has moved over a multi-month window and where it sits inside its own 52-week range; a high reading means both sit near the top of the scale. The weakest factor is Smart Money at 10/100 — well below average net of disclosed SEC Form 4 insider transactions. The insider transactions disclosed for PCRX in the window net toward selling; on a thinly filed name a few filings can set this reading.
Generated from the six-factor breakdown above. Changes when the underlying scores do, usually about once a day. Methodology detail at /how-it-works.
See PCRX in the scanner
This page, the daily Top 10, the whole scorecard and the raw CSV/JSON record are free to read with no account at all. Signing up takes an email and a password: a free account runs the scanner on the top 10 scored rows of any scan, keeps one saved screen, a 5-ticker watchlist, and opens 12 ticker deep-pages a day. The card is what starts a 30-day Premium trial — $0 that day, the first charge on day 30 at the plan you pick, one click to cancel before then — and that is what turns on every matching row instead of the first 10, alerts, CSV export, the 200-ticker watchlist and recent insider buys (SEC Form 4).
Recent PCRX news
Latest market-moving headlines mentioning PCRX, sourced from Tapeline’s news feed (Polygon/Massive + Finnhub).
- Pacira Biosciences (NASDAQ:PCRX): An Undervalued Value Stock Backed by Cash Flow and Balance Sheet StrengthChartMill
- Pacira BioSciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)Yahoo
- Leerink Partners Initiates Coverage On Pacira BioSciences with Market Perform Rating, Announces Price Target of $28Benzinga
- Pacira (PCRX) Up 6.9% Since Last Earnings Report: Can It Continue?Zacks Investment Research+2 other tickers
- Pacira (PCRX) Up 6.9% Since Last Earnings Report: Can It Continue?Yahoo
Saved snapshot; the news and prices on this page can be an hour old or more.
Similar setups in Health Care right now
Six health care tickers with composite scores closest to PCRX’s 44 — same factor environment, sortable on the scanner.
Sorted by closeness to PCRX’s composite score within Health Care. Saved snapshot; can be an hour old or more. Run the full scanner →
Frequently asked about PCRX
What is the Tapeline Score for PCRX?
+
PCRX (Pacira Biosciences Inc) currently scores 44/100 with the signal label NEUTRAL. The score is a weighted blend of six quantitative factors. It is recalculated about every 60 seconds during US market hours, but most of its inputs are daily readings, so it usually changes about once a day. Prices are delayed about 15 minutes.
How is PCRX's score calculated?
+
The Tapeline Score is a transparent weighted blend of six named factors: Trend, Relative Strength, Fundamentals, Smart Money, Macro, and Momentum — weighted most toward Trend and Relative Strength, and least toward Momentum. Each sub-score is normalised to 0-100 and the methodology is published on /how-it-works.
Is PCRX a buy?
+
Tapeline doesn't issue buy or sell calls — we publish descriptive analytics, not investment advice. The signal label NEUTRAL describes the current state of the data; whether PCRX fits your portfolio depends on your risk tolerance, time horizon, and tax situation. See the risk disclosure for details.
How often does the PCRX score update?
+
PCRX's score is recalculated about every 60 seconds during US market hours and persists between sessions, but it usually changes about once a day: trend, relative strength and momentum come from daily price bars, and prices themselves are delayed about 15 minutes; fundamentals refresh on company filing cadence; insider Form 4 filings are read from SEC EDGAR and re-checked about every two days for stocks (about monthly for ETFs).
Where can I see the historical track record for Tapeline scores?
+
Each day's Tapeline top 10 is published with its next-day return vs SPY at /scorecard. Entries are not re-ranked or deleted. We have corrected recorded values twice, and said so: prices on 25 August 2026, and scores from 18 May to 12 June capped on 15 June 2026. No top 10 was recorded for 31 August, 2 September, 4 September or 9 September 2026.
What does the NEUTRAL signal mean for PCRX?
+
NEUTRAL is a descriptive band on the Tapeline composite. HIGH CONVICTION (85-100) means all six factors aligned; STRONG SETUP (70-84) typically four-or-five-of-six; CONSTRUCTIVE (55-69) net-positive with tradeoffs; NEUTRAL (40-54) factors cancel; CAUTION (25-39) more negative than positive; WEAK (0-24) broadly negative. PCRX sitting at NEUTRAL means the data right now reads as neutral for the six-factor profile.
Is PCRX better for swing trading or day trading?
+
The Tapeline composite is calibrated for multi-day setups — the heaviest-weighted factors (Trend, Relative Strength, and Fundamentals) reward stability over a horizon of days-to-weeks. For pure day trading, the 1-day move + sub-momentum factor is more relevant. Use /best-stocks-for/day-traders for the day-trader-sorted view and /best-stocks-for/swing-traders for the multi-day setup view.
Where does PCRX rank in the health care sector?
+
PCRX scores in the 48th percentile of Health Care by composite score (n=1,099 covered peers) this session. Peer percentiles are computed across every ticker in the peer group Tapeline holds a composite score for, always print the covered-peer count (n) they were computed against, and move when the peers' scores change, which is usually about once a day.
Does Tapeline have insider buying data for PCRX?
+
PCRX's Smart Money sub-score reads disclosed SEC Form 4 insider transactions, netted over a recent window. Detailed Form 4 history per ticker is a Premium feature; the aggregate Smart Money sub-score is shown on this page for free.
Why does PCRX's score change between visits?
+
Scores are recalculated about every 60 seconds during US market hours, but most inputs are daily readings, so a score usually changes about once a day. Trend, Relative Strength and Momentum come from daily price bars; Macro responds to changes in the market-wide regime classification, whose inputs are daily; Smart Money updates on filing cadence; Fundamentals on the quarterly earnings cycle. This page is also a saved snapshot that can be an hour old or more, so two visits can show different readings.
Can I get alerts when PCRX's score changes?
+
Yes, on a paid plan — Pro gets email alerts on configurable triggers (score crosses a threshold, market regime changes, news on a ticker), and Premium raises the daily email-alert cap from 10 to 50. Alerts are one of the lines between the plans: the free plan sends none, on any channel. What it does give you is scores on the top 10 scanner rows, one saved screen, a 5-ticker watchlist and 12 look-ups a day, so PCRX alerts specifically need the 30-day Premium trial or a paid plan.
How does PCRX's Tapeline Score compare to a Finviz screener result?
+
Finviz exposes raw filter fields — you build a thesis from the data. Tapeline synthesises six factors into one composite + a plain-English Why, so the work is done before you look at the row. Both are useful for different jobs: Finviz Elite for power-user raw-filter scans, Tapeline for daily synthesised rankings + per-pick public scorecard. Many traders use both — see /best-finviz-alternatives for the head-to-head comparison.
Prices delayed about 15 minutes; scores usually change about once a day. Public methodology. Public scorecard. Not investment advice — see risk disclosure.
See this ticker scored each market morning
Get the Tapeline daily Top 10 in your inbox. One email, no card, unsubscribe in one click.